News | Magnetic Resonance Imaging (MRI) | August 28, 2019

New MRI Technique Spots Heart Muscle Scarring Without Kidney Damage

3D MRI computing can measure strain in the heart using image registration method without gadolinium

Displacement comparison at the end-systolic frame and final frame

Displacement comparison at the end-systolic frame and final frame. The three patients (V6, V10, V16) with different left-ventricle walls are shown. Point-to-surface distance is a measure to estimate the distance of a point from the reference surface. Image courtesy of WMG, University of Warwick


August 28, 2019 — A new 3-D magnetic resonance imaging (MRI) computing technique developed by scientists in WMG at the University of Warwick focuses on hierarchical template matching (HTM) to diagnose cardiac disease without the use of gadolinium contrast. The technique is explored in an article in the journal Scientific Reports.1

MRI has long been used to diagnose cardiomyopathy, heart attacks, irregular heartbeats and other heart disease. Traditionally when a patient goes for an MRI scan they are given a dose of gadolinium, which reacts with the magnetic field of the scanner to produce an image of the protons in the metal realigning with the field. The faster the protons realign, the brighter the image features to show where the dead muscles are in the heart and what the diagnosis is. 

The dose of gadolinium, however, can have detrimental effects to other parts of the body, particularly the risk of kidney failure. 

The hierarchical template matching technique involves:

  • A numerically stable technique of left ventricular (LV) myocardial tracking;

  • A 3-D extension of local weighted mean function to transform MRI pixels; and

  • A 3-D extension of the HTM model for myocardial tracking problems.

Use of this technique eliminates the need for gadolinium, reducing the risk of damage to other organs. 

Prof. Mark Williams from WMG at the University of Warwick said, “Using 3D MRI computing technique we can see in more depth what is happening to the heart, more precisely to each heart muscle, and diagnose any issues such as remodeling of the heart that causes heart failure. The new method avoids the risk of damaging the kidney opposite to what traditional methods do by using gadolinium.” 

Jayendra Bhalodiya, who conducted the research from WMG, University of Warwick added, “This new MRI technique also takes away stress from the patient, as during an MRI the patient must be very still in a very enclosed environment, meaning some people suffer from claustrophobia and have to stop the scan. Often when they do this they have to administer another dose of the damaging gadolinium and start again. This technique doesn’t require a dosage of anything, as it tracks the heart naturally.”

For more information: www.nature.com

Related Content

FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients

Concerns Over Gadolinium MRI Contrast Toxicity

VIDEO: How Serious is MRI Gadolinium Retention in the Brain and Body?

Reference

1. Bhalodiya J.M., Palit A., Ferrante E., et al. Hierarchical Template Matching for 3D Myocardial Tracking and Cardiac Strain Estimation. Nature Scientific Reports, published online Aug. 28, 2019. https://doi.org/10.1038/s41598-019-48927-2


Related Content

News | Cardiac Imaging

Dec. 1, 2025 — Cleerly, a provider of AI-based cardiovascular imaging, will showcase new product updates at RSNA 2025 ...

Home December 02, 2025
Home
News | Cardiac Imaging

Nov. 30, 2025 — KA Imaging Technology has announced that its Reveal 35C detector with SpectralDR technology will be ...

Home December 01, 2025
Home
News | Cardiac Imaging

Nov. 13, 2025 — Esaote has announced a new strategic partnership with Schiller Americas. This collaboration strengthens ...

Home November 14, 2025
Home
News | Cardiac Imaging

Oct. 1, 2025 – Intelerad has announced the next generation of InteleHeart, a reimagined, all-in-one cardiology platform ...

Home October 02, 2025
Home
News | Cardiac Imaging

Sept. 22, 2025 — Heartflow, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Next Gen ...

Home September 23, 2025
Home
News | Cardiac Imaging

Aug. 13, 2025 — BioCardia, Inc., a provider of cellular and cell-derived therapeutics for treating cardiovascular and ...

Home August 15, 2025
Home
News | Cardiac Imaging

July 28, 2025 — Frost & Sullivan has named Siemens Healthineers the 2025 North America Company of the Year in the ...

Home July 28, 2025
Home
News | Cardiac Imaging

July 25, 2025 — Data in recent staffing surveys from the American Society of Radiologic Technologists show that vacancy ...

Home July 25, 2025
Home
News | Cardiac Imaging

July 17, 2025— Heartflow, Inc. recently announced new data for its AI-enabled Heartflow Plaque Analysis, including final ...

Home July 17, 2025
Home
News | Cardiac Imaging

July 15, 2025 – Cleerly has announced that EviCore, a leading radiology benefit manager providing coverage guidelines to ...

Home July 16, 2025
Home
Subscribe Now